Citations 1
Effect of anti-CTGF human recombinant monoclonal antibody pamrevlumab on resectability and resection rate when combined with gemcitabine/nab-paclitaxel in phase 1/2 clinical study for the treatment of locally advanced pancreatic cancer patients.
Picozzi, Vincent J. , Pishvaian, Michael J. , Mody, Kabir , Larson, Tim , Matrana, Marc , Saikali, Khalil G., Carney, Mairead, Porter, Seth, Yu, Peony, Kouchakji, Elias, Carrier, Ewa , Winter, Jordan Michael , Glaspy, John A. , Larson, Tim
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 4016-4016
